{"id":"https://openalex.org/W7208711409","doi":"https://doi.org/10.64898/2026.09.01.26361904","title":"Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma","display_name":"Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma","publication_year":2026,"publication_date":"2026-09-03","ids":{"openalex":"https://openalex.org/W7208711409","doi":"https://doi.org/10.64898/2026.09.01.26361904"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.01.26361904","doi":"https://doi.org/10.64898/2026.09.01.26361904","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.01.26361904","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/03/2026.09.01.26361904.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/03/2026.09.01.26361904.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5140992892","display_name":"Laura Camacho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura Camacho","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069462976","display_name":"Cristina Cacho-Navas","orcid":"https://orcid.org/0000-0002-7778-075X","observed_orcids":["https://orcid.org/0000-0002-7778-075X"]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristina Cacho-Navas","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143482468","display_name":"Jon Ag\u00fcero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jon Ag\u00fcero","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118979093","display_name":"Baterdene Batmunkh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Baterdene Batmunkh","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136977472","display_name":"Jose Maria Gracia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Mar\u00eda Gracia","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149983821","display_name":"Killian O Sullivan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Killian O\u2019 Sullivan","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118979094","display_name":"Markel Rementeria","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Markel Rementeria","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011820835","display_name":"James Miles","orcid":"https://orcid.org/0009-0001-9560-6026","observed_orcids":["https://orcid.org/0009-0001-9560-6026"]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"James Miles","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062251234","display_name":"Juan Gumuzio","orcid":"https://orcid.org/0000-0003-1258-0025","observed_orcids":["https://orcid.org/0000-0003-1258-0025"]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Gumuzio","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141002681","display_name":"Fernando Aguirre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Fernando Aguirre","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140793408","display_name":"Salvador Mart\u00edn Algarra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Salvador Martin Algarra","raw_affiliation_strings":["Facultad de Medicina, Departamento de Oncolog\u00eda, Cl\u00ednica Universidad de Navarra (CUN), 31008 Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facultad de Medicina, Departamento de Oncolog\u00eda, Cl\u00ednica Universidad de Navarra (CUN), 31008 Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104240669","display_name":"Carlos Eduardo de Andrea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]},{"id":"https://openalex.org/I88155538","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23","country_code":"ES","type":"education","lineage":["https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Eduardo de Andrea","raw_affiliation_strings":["Facultad de Medicina, Departamento de Patolog\u00eda, Anatom\u00eda y Fisiolog\u00eda, Cl\u00ednica Universidad de Navarra (CUN), 31008 Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facultad de Medicina, Departamento de Patolog\u00eda, Anatom\u00eda y Fisiolog\u00eda, Cl\u00ednica Universidad de Navarra (CUN), 31008 Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003","https://openalex.org/I88155538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101403547","display_name":"Peter J. Parker","orcid":"https://orcid.org/0000-0001-5907-6980","observed_orcids":["https://orcid.org/0000-0001-5907-6980"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I2801081054","display_name":"The Francis Crick Institute","ror":"https://ror.org/04tnbqb63","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter J. Parker","raw_affiliation_strings":["Francis Crick Institute, NW1 1AT, London, United Kingdom","School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King\u2019s College London, SE1 1UL, London, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-5907-6980","affiliations":[{"raw_affiliation_string":"Francis Crick Institute, NW1 1AT, London, United Kingdom","institution_ids":["https://openalex.org/I2801081054"]},{"raw_affiliation_string":"School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King\u2019s College London, SE1 1UL, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046776874","display_name":"V\u00e9ronique Calleja","orcid":"https://orcid.org/0000-0002-6537-2660","observed_orcids":["https://orcid.org/0000-0002-6537-2660"]},"institutions":[{"id":"https://openalex.org/I4210133416","display_name":"Fastbase Solutions (Spain)","ror":"https://ror.org/03y81kj05","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210133416"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"V\u00e9ronique Calleja","raw_affiliation_strings":["HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain"],"raw_orcid":"https://orcid.org/0000-0002-6537-2660","affiliations":[{"raw_affiliation_string":"HAWK Biosystems (FASTBASE Solutions S.L.) 612 Astondo Bidea, Science and Technology Park of Bizkaia, 48160 Derio, Spain","institution_ids":["https://openalex.org/I4210133416"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5046776874"],"corresponding_institution_ids":["https://openalex.org/I4210133416"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flim-fret","display_name":"FLIM-FRET","score":0.7919999957084656},{"id":"https://openalex.org/keywords/multiplexed-imaging","display_name":"multiplexed imaging","score":0.6949999928474426},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.8920000195503235},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pd-1-pd-l1","display_name":"PD-1/PD-L1","score":0.9700000286102295},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9869999885559082},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.8500000238418579},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.40799999237060547},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4050000011920929},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9273999929428101},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6549999713897705},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6503999829292297},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.5995000004768372},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5759999752044678},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.49939998984336853},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4921000003814697},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.45500001311302185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4262999892234802},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4172999858856201},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4129999876022339},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.36579999327659607},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.3490999937057495},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3490000069141388},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.2784000039100647},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27230000495910645},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.26570001244544983}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.01.26361904","doi":"https://doi.org/10.64898/2026.09.01.26361904","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.01.26361904","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/03/2026.09.01.26361904.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.01.26361904","doi":"https://doi.org/10.64898/2026.09.01.26361904","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.01.26361904","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/03/2026.09.01.26361904.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G121809054","display_name":null,"funder_award_id":"MCIN/AEI/10","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G1855990336","display_name":null,"funder_award_id":".13039/501100011033","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G2309174360","display_name":null,"funder_award_id":"10.13039","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G2660406951","display_name":null,"funder_award_id":"/ AEI/10","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G279363373","display_name":null,"funder_award_id":"MCIN/AEI/10.13039/501100011033,","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G3518538256","display_name":null,"funder_award_id":"13039","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G430777504","display_name":null,"funder_award_id":"10.13039/501100011033/","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G5421974903","display_name":null,"funder_award_id":"501100011033","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G897484643","display_name":null,"funder_award_id":"MCIN /AEI /10.13039","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"},{"id":"https://openalex.org/G99296377","display_name":null,"funder_award_id":"/AEI/10.13039/ 501100011033","funder_id":"https://openalex.org/F4320322930","funder_display_name":"Ministerio de Ciencia e Innovaci\u00f3n"}],"funders":[{"id":"https://openalex.org/F4320322930","display_name":"Ministerio de Ciencia e Innovaci\u00f3n","ror":null},{"id":"https://openalex.org/F4320335598","display_name":"Agencia Estatal de Investigaci\u00f3n","ror":"https://ror.org/003x0zc53"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7208711409.pdf","grobid_xml":"https://content.openalex.org/works/W7208711409.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1969096316","https://openalex.org/W2289712604","https://openalex.org/W2559804019","https://openalex.org/W2783970157","https://openalex.org/W2890398072","https://openalex.org/W2946620483","https://openalex.org/W3010579821","https://openalex.org/W3049244168","https://openalex.org/W3087466624","https://openalex.org/W3120351359","https://openalex.org/W3193373882","https://openalex.org/W4221034977","https://openalex.org/W4321606672","https://openalex.org/W4379791505","https://openalex.org/W4392520083","https://openalex.org/W4402223838","https://openalex.org/W4408462460","https://openalex.org/W4413052331","https://openalex.org/W7168612500","https://openalex.org/W7170140674"],"related_works":["https://openalex.org/W4413052331","https://openalex.org/W7170140674","https://openalex.org/W2186633408","https://openalex.org/W7154752621","https://openalex.org/W3009208682","https://openalex.org/W4392267814","https://openalex.org/W2785803176","https://openalex.org/W3155229268","https://openalex.org/W2916292904","https://openalex.org/W2955456037"],"abstract_inverted_index":{"Abstract":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"targeting":[4],"the":[5,21,52,58,65,83,116,140,154,161],"PD-1/PD-L1":[6,106,147],"axis":[7],"have":[8,44],"shown":[9,46],"great":[10],"promise":[11],"in":[12,92,115,167,173],"treating":[13],"bladder":[14],"cancer":[15],"and":[16,36,57,88,110,148],"are":[17,41],"now":[18],"part":[19],"of":[20,54,60,85,96,143,163],"standard":[22],"treatment":[23,35,111],"for":[24,67],"advanced":[25],"disease.":[26],"However,":[27],"many":[28,39],"patients":[29,98,123,128,144,175],"still":[30],"fail":[31],"to":[32,34,137,152],"respond":[33],"at":[37],"present":[38],"biomarkers":[40,70],"assessed":[42],"but":[43],"yet":[45],"only":[47],"limited":[48],"results.":[49],"Therefore,":[50],"with":[51,100,124,145],"advent":[53],"combination":[55,180],"treatments":[56],"increase":[59],"immune":[61,90,165],"related":[62],"adverse":[63],"event,":[64],"search":[66],"reliable":[68],"predictive":[69],"is":[71],"paramount.":[72],"Using":[73],"a":[74,93,134],"multiplexed":[75],"enhanced":[76],"FRET-FLIM":[77],"based":[78],"technique":[79],"(\u01eaF-Pro)":[80],"we":[81],"quantified":[82],"interaction":[84,108],"PD-1/PD-L1,":[86],"CTLA-4/CD80":[87,131,150],"TIGIT/CD155":[89],"checkpoints":[91],"pre-treatment":[94],"TMA":[95],"46":[97],"treated":[99],"atezolizumab.":[101,138],"The":[102],"association":[103],"between":[104],"higher":[105,130],"ICP":[107],"state":[109],"efficacy":[112],"was":[113],"demonstrated":[114],"male":[117],"sample":[118],"cohort,":[119],"where":[120],"it":[121],"identified":[122],"better":[125],"PFS.":[126],"Conversely,":[127],"exhibiting":[129],"engagement":[132],"had":[133],"worse":[135],"response":[136],"Remarkably,":[139],"dual":[141],"assessment":[142],"high":[146],"low":[149],"allowed":[151],"identify":[153],"best":[155],"responders.":[156],"These":[157],"results":[158],"indicate":[159],"that":[160],"monitoring":[162],"patients\u2019":[164],"profile":[166],"urothelial":[168],"carcinoma":[169],"might":[170],"be":[171],"critical":[172],"identifying":[174],"who":[176],"may":[177],"benefit":[178],"from":[179],"therapy.":[181]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-09-05T00:00:00"}